Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 29

1.

Proton beam therapy outcomes for localized unresectable hepatocellular carcinoma.

Chadha AS, Gunther JR, Hsieh CE, Aliru M, Mahadevan LS, Venkatesulu BP, Crane CH, Das P, Herman JM, Koay EJ, Taniguchi C, Holliday EB, Minsky BD, Suh Y, Park P, Sawakuchi G, Beddar S, Odisio BC, Gupta S, Loyer E, Kaur H, Raghav K, Javle MM, Kaseb AO, Krishnan S.

Radiother Oncol. 2019 Apr;133:54-61. doi: 10.1016/j.radonc.2018.10.041. Epub 2019 Jan 16.

PMID:
30935582
2.

Preoperative drainage for perihilar cholangiocarcinoma.

Odisio BC, Krampitz GW, Murthy R, Mahvash A, Javle M, Vauthey JN.

Lancet Gastroenterol Hepatol. 2019 Jan;4(1):10-11. doi: 10.1016/S2468-1253(18)30345-5. Epub 2018 Dec 6. No abstract available.

PMID:
30527574
3.

Comparative Analysis of Intra-arterial Cone-Beam Versus Conventional Computed Tomography During Hepatic Arteriography for Transarterial Chemoembolization Planning.

Lin EY, Jones AK, Chintalapani G, Jeng ZS, Ensor J, Odisio BC.

Cardiovasc Intervent Radiol. 2019 Apr;42(4):591-600. doi: 10.1007/s00270-018-2116-8. Epub 2018 Nov 9.

PMID:
30413918
4.

Integrated CT-Fluoroscopy Equipment: Improving the Interventional Radiology Approach and Patient Experience for Treatment of Musculoskeletal Malignancies.

Yevich S, Odisio BC, Sheth R, Tselikas L, de Baère T, Deschamps F.

Semin Intervent Radiol. 2018 Oct;35(4):229-237. doi: 10.1055/s-0038-1669962. Epub 2018 Nov 5. Review.

PMID:
30402005
5.

Comprehensive Complication Index Validates Improved Outcomes Over Time Despite Increased Complexity in 3707 Consecutive Hepatectomies.

Cloyd JM, Mizuno T, Kawaguchi Y, Lillemoe HA, Karagkounis G, Omichi K, Chun YS, Conrad C, Tzeng CD, Odisio BC, Huang SY, Hicks M, Wei SH, Aloia TA, Vauthey JN.

Ann Surg. 2018 Oct 17. doi: 10.1097/SLA.0000000000003043. [Epub ahead of print]

PMID:
30339628
6.

Comment on Letter to the Editor Regarding "ALPPS Improves Resectability Compared With Conventional Two-stage Hepatectomy in Patients With Advanced Colorectal Liver Metastasis: When Innovation is Not Enough".

Vega EA, Simoneau E, Tzeng CD, Odisio BC, Aloia TA, Chun YS, Vauthey JN.

Ann Surg. 2019 Aug;270(2):e35-e36. doi: 10.1097/SLA.0000000000003025. No abstract available.

PMID:
30169392
7.

Fast-Track Two-Stage Hepatectomy Using a Hybrid Interventional Radiology/Operating Suite as Alternative Option to Associated Liver Partition and Portal Vein Ligation for Staged Hepatectomy Procedure.

Odisio BC, Simoneau E, Holmes AA, Conrad CH, Vauthey JN.

J Am Coll Surg. 2018 Aug;227(2):e5-e10. doi: 10.1016/j.jamcollsurg.2018.04.027. Epub 2018 May 4. No abstract available.

PMID:
29729926
8.

Baseline Apparent Diffusion Coefficient as a Predictor of Response to Liver-Directed Therapies in Hepatocellular Carcinoma.

Niekamp A, Abdel-Wahab R, Kuban J, Odisio BC, Mahvash A, Hassan MM, Qayyum A, Kaseb A, Sheth RA.

J Clin Med. 2018 Apr 14;7(4). pii: E83. doi: 10.3390/jcm7040083.

9.

Ablation of colorectal liver metastasis: Interaction of ablation margins and RAS mutation profiling on local tumour progression-free survival.

Calandri M, Yamashita S, Gazzera C, Fonio P, Veltri A, Bustreo S, Sheth RA, Yevich SM, Vauthey JN, Odisio BC.

Eur Radiol. 2018 Jul;28(7):2727-2734. doi: 10.1007/s00330-017-5273-2. Epub 2018 Feb 7.

PMID:
29417253
10.

Impact of Prior Hepatectomy History on Local Tumor Progression after Percutaneous Ablation of Colorectal Liver Metastases.

Odisio BC, Yamashita S, Huang SY, Kopetz SE, Ahrar K, Mizuno T, Conrad C, Aloia TA, Chun YS, Gupta S, Vauthey JN.

J Vasc Interv Radiol. 2018 Mar;29(3):395-403.e1. doi: 10.1016/j.jvir.2017.10.026. Epub 2018 Feb 1.

11.

Anti-angiogenic therapy in the setting of TACE: an elusive synergy?

Odisio BC, Kaseb AO.

Lancet Gastroenterol Hepatol. 2018 Jan;3(1):5-6. doi: 10.1016/S2468-1253(17)30324-2. Epub 2017 Oct 4. No abstract available.

PMID:
28988686
12.

Natural History of T1N0M0 Hepatocellular Carcinoma: Large-Scale Study in the United States.

Al-Shamsi HO, Abdel-Wahab R, Hassan MM, Shalaby AS, Dahbour I, Lacin S, Mahvash A, Odisio BC, Murthy R, Avritscher R, Abdelsalam ME, Rashid A, Vauthey JN, Aloia TA, Conrad C, Chun YS, Krishnan S, Das P, Koay EJ, Amin HM, Yao JC, Kaseb AO.

Oncology. 2017;93(4):233-242. doi: 10.1159/000455957. Epub 2017 Jul 6.

PMID:
28683459
13.

Management of unresectable intrahepatic cholangiocarcinoma: how do we decide among the various liver-directed treatments?

Koay EJ, Odisio BC, Javle M, Vauthey JN, Crane CH.

Hepatobiliary Surg Nutr. 2017 Apr;6(2):105-116. doi: 10.21037/hbsn.2017.01.16. Review.

14.

Prognostic value of incidental hypervascular micronodules detected on cone-beam computed tomography angiography of patients with liver metastasis.

Odisio BC, Cox VL, Faria SC, Yamashita S, Shi X, Ensor J, Jones AK, Mahvash A, Gupta S, Tam AL, Vauthey JN, Murthy R.

Eur Radiol. 2017 Nov;27(11):4837-4845. doi: 10.1007/s00330-017-4847-3. Epub 2017 May 8.

PMID:
28484824
15.

Development of a predictive model for 6 month survival in patients with venous thromboembolism and solid malignancy requiring IVC filter placement.

Huang SY, Odisio BC, Sabir SH, Ensor JE, Niekamp AS, Huynh TT, Kroll M, Gupta S.

J Thromb Thrombolysis. 2017 Jul;44(1):30-37. doi: 10.1007/s11239-017-1493-1.

16.

Planned Treatment of Advanced Metastatic Disease with Completion Ablation After Hepatic Resection.

Odisio BC, Yamashita S, Frota L, Huang SY, Kopetz SE, Ahrar K, Chun YS, Aloia TA, Hicks ME, Gupta S, Vauthey JN.

J Gastrointest Surg. 2017 Apr;21(4):628-635. doi: 10.1007/s11605-016-3324-7. Epub 2016 Nov 23.

PMID:
27882510
17.

Efficacy of a Self-expanding Tract Sealant Device in the Reduction of Pneumothorax and Chest Tube Placement Rates After Percutaneous Lung Biopsy: A Matched Controlled Study Using Propensity Score Analysis.

Ahrar JU, Gupta S, Ensor JE, Mahvash A, Sabir SH, Steele JR, McRae SE, Avritscher R, Huang SY, Odisio BC, Murthy R, Ahrar K, Wallace MJ, Tam AL.

Cardiovasc Intervent Radiol. 2017 Feb;40(2):270-276. doi: 10.1007/s00270-016-1489-9. Epub 2016 Nov 8.

18.

Minimally invasive image-guided therapies for hepatocellular carcinoma.

Abdelsalam ME, Murthy R, Avritscher R, Mahvash A, Wallace MJ, Kaseb AO, Odisio BC.

J Hepatocell Carcinoma. 2016 Oct 11;3:55-61. eCollection 2016. Review.

19.

Yttrium-90 resin microspheres as an adjunct to sorafenib in patients with unresectable hepatocellular carcinoma.

Mahvash A, Murthy R, Odisio BC, Raghav KP, Girard L, Cheung S, Nguyen V, Ensor J, Gadani S, Elsayes KM, Abdel-Wahab R, Hassan M, Shalaby AS, Yao JC, Wallace MJ, Kaseb AO.

J Hepatocell Carcinoma. 2016 Feb 5;3:1-7. doi: 10.2147/JHC.S62261. eCollection 2016.

20.

Use of Prophylactic Antibiotics to Prevent Abscess Formation Following Hepatic Ablation in Patients with Prior Enterobiliary Manipulation.

Odisio BC, Richter M, Aloia TA, Conrad C, Ahrar K, Gupta S, Vauthey JN, Huang SY.

J Gastrointest Surg. 2016 Aug;20(8):1428-34. doi: 10.1007/s11605-016-3117-z. Epub 2016 Mar 16.

Supplemental Content

Loading ...
Support Center